Industry Briefs: June 4, 2012

Published on: 

A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.

Company News

AMRI Burlington has been contracted as an aseptic fill manufacturer for the market introduction of Cardium Therapeutics’s and its subsidiary, Tissue Repair Company’s, wound-care product Excellagen. Read More

Baxter International has entered into an agreement with Chatham Therapeutics for development and commercialization of Chatham’s Factor IX hemophilia B gene-therapy treatment. Read More

Bayer HealthCare has formed a partnership with Covance for clinical drug development, including R&D services related to Phase II–IV clinical studies and central laboratory services. Read More

Bristol-Myers Squibb has partnered with 10 cancer-research centers in immuno-oncology. Read More

Catalent Pharma Solutions has signed a definitive agreement to sell its US commercial-packaging operations based in Philadelphia, Pennsylvania, and Woodstock, Illinois, to a company affiliated with Frazier Healthcare. The transaction is subject to certain closing conditions and is expected to close in the next few months. Read More

Forest Laboratories and Nabriva Therapeutics have entered into a $25-million agreement for the development of Nabriva’s novel antibacterial agent, BC-3781. Read More

Genmab and Novartis have agreed to use Genmab’s DuoBody technology platform to create and develop bispecific antibodies. Read More


JHP Pharmaceuticals has entered into an agreement with an undisclosed pharmaceutical company to produce the clinical and commercial supply of an innovative injectable used in the cardiovascular setting. Read More

Mylan has received FDA approval to launch a generic version of Pfizer’s Lipitor (atorvastatin calcium). Read More

WuXi PharmTech has commented on the conviction of a former employee for the theft of Merck compounds. Read More

People News

BioStorage Technologies has appointed Kristina Robson as senior director of comprehensive solutions. Read More

William G. Kaelin, Jr. has been elected to Eli Lilly's board of directors. Read More